Trial Profile
A retrospective ,multicenter, cohort trial to evaluate the efficacy and safety of telaprevir versus simeprevir based triple therapy in patients with hepatitis C after living donor liver transplantation
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 19 Jan 2017
Price :
$35
*
At a glance
- Drugs Simeprevir (Primary) ; Telaprevir (Primary) ; Peginterferon alfa-2a; Peginterferon alfa-2b; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- 01 Dec 2016 Results assessing efficacy and safety published in the Hepatology Research.
- 18 Apr 2016 New trial record
- 01 Mar 2016 Results published in the Hepatology Research